New hope for vitiligo: experimental drug FB102 enters human trials

NCT ID NCT06905873

First seen Nov 20, 2025 · Last updated May 14, 2026 · Updated 24 times

Summary

This study tests a new medicine called FB102 for people with non-segmental vitiligo, a condition that causes white patches on the skin. The trial will include 64 adults and aims to see if FB102 is safe and can help restore skin color on the face. Participants will receive either FB102 or a placebo, and neither they nor the doctors will know who gets which.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VITILIGO are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Cornerstone Dermatology

    RECRUITING

    Coorparoo, Queensland, 4151, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Momentum Pukehoke

    RECRUITING

    Auckland, Auckland, 2120, New Zealand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Novatrials

    RECRUITING

    Kotara, New South Wales, 2289, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Optimal Clinical Trials Central

    RECRUITING

    Auckland, Auckland, 1010, New Zealand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Optimal Clinical Trials North

    RECRUITING

    Auckland, Auckland, 0632, New Zealand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Skin & Cancer Foundation Australia - The Skin Hospital

    RECRUITING

    Darlinghurst, New South Wales, 2010, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.